Skip to main content

Stories by David Stipp


Quest for Anti-Aging Drugs Transitions from Flaky to Mainstream

When I give talks on aging research someone usually asks, “When will scientists develop true anti-aging drugs?” My answer has little to do with what’s happening in the lab, though—it’s about politics, perceptions and money.It has been clear for many years that the rate of aging is malleable in diverse species, and the discovery in 2009 that a drug called rapamycin can extend maximum life span in mice suggested that it’s now technically feasible to develop anti-aging agents that really work as advertised...

December 20, 2011 — David Stipp
Scroll To Top